
Counterfeiting, fraud, and theft within the pharmaceutical industry's supply chain
ranges from conservative estimates of $30 billion to more than $50 billion in
annual losses to corporations, according to market studies by PIRA International,
IMS Health, and the U.S. Food & Drug Administration (FDA). The FDA and
pharmaceutical industry groups are calling for devices that minimize counterfeits,
curb abuse and improve patient compliance. ViaNase ID
TM
addresses all three requirements.
With built-in electronics and power, ViaNase ID includes the following features:
- Authentication ViaNase ID can recognize specific drug information such as product identification, expiration date, etc. by reading a coding technology placed on the drug packaging or unit dose ampoule. Based on the information read, ViaNase sets operational parameters.
- Lockout control ViaNase ID will power up only if it reads the correct product ID and the drug is not past its expiration date.
- Designated user control ViaNase ID will power up only if it recognizes a permitted caregiver or parent identification code.
- Operational parameter control - Based on drug type, the following variable parameters are set:
- Optimized droplet size and atomization rate
- Vortex characteristics
- Breath activation
- Cleaning cycle designated
- Dosing controls - ViaNase ID can increase patient compliance rates by:
- Setting specific atomization time in min/day or number of doses/day
- Setting the total number of doses per prescription
- Sounding an alarm when a dose is required
- Data storage and transmission - Information such as drug ID, drug type,
time/date of doses, total amount of drug delivered, and operating parameter records can
be saved to a data storage card or downloaded to a PC or PDA. This information is useful
for physicians, pharmacies and clinical trial coordinators.